Back to Rankings

XFOR

X4C
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
XFOR vs peer average
59/100
XFOR vs. peer average (C vs. D)
Grade spread
A 1 · B 2 · C 1 · D 4 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

LRMR is the first available peer comparator.

Small-cap biotech with similar milestone-driven trading behavior and capital-markets sensitivity; a better volatility comparator than a direct operating peer.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerLRMRLarimar Therapeutics
XFOR
X4
LRMR
Larimar Therapeutics
Grade
C
D
Momentum
56
3
Value
41
41
Sentiment
67
100
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Defensive

Grade position vs LRMR

XFOR / LRMR
Grade Position
In line
XFOR vs. peer average (C vs. D)
59/100
Momentum
56
XFOR
Value
41
XFOR
Sentiment
67
LRMR

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs XFOR
1
LRMR
LRMR
D
40/100
+1
2
PBYI
PBYI
B
80/100
-1
3
CCCC
CCCC
C
60/100
Even
4
VNDA
Vanda Pharmaceuticals Inc Common
D
40/100
+1
5
FBRX
Forte Biosciences Inc Common
F
20/100
+2
LRMR is the first peer returned for this comparison set.